prikaz prve stranice dokumenta Serum lipid levels and suicidality among male patients with schizoaffective disorder
  Preuzmi
PDF 126.64 KB
Znanstveni rad - Izvorni znanstveni rad
Serum lipid levels and suicidality among male patients with schizoaffective disorder
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32 (2008), 1; 193-196. https://doi.org/10.1016/j.pnpbp.2007.08.009
Marčinko, Darko; Marčinko, Vesna; Karlović, Dalibor; Marčinko, Anita; Martinac, Marko; Begić, Dražen; Jakovljević, Miro

Citirajte ovaj rad

Marčinko, D., Marčinko, V., Karlović, D., Marčinko, A., Martinac, M., Begić, D. i Jakovljević, M. (2008). Serum lipid levels and suicidality among male patients with schizoaffective disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32. (1), 193-196. doi: 10.1016/j.pnpbp.2007.08.009

Marčinko, Darko, et al. "Serum lipid levels and suicidality among male patients with schizoaffective disorder." Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, br. 1, 2008, str. 193-196. https://doi.org/10.1016/j.pnpbp.2007.08.009

Marčinko, Darko, Vesna Marčinko, Dalibor Karlović, Anita Marčinko, Marko Martinac, Dražen Begić i Miro Jakovljević. "Serum lipid levels and suicidality among male patients with schizoaffective disorder." Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, br. 1 (2008): 193-196. https://doi.org/10.1016/j.pnpbp.2007.08.009

Marčinko, D., et al. (2008) 'Serum lipid levels and suicidality among male patients with schizoaffective disorder', Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(1), str. 193-196. doi: 10.1016/j.pnpbp.2007.08.009

Marčinko D, Marčinko V, Karlović D, Marčinko A, Martinac M, Begić D, i sur.. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry [Internet]. 01.2008. [pristupljeno 09.05.2024.];32(1):193-196. doi: 10.1016/j.pnpbp.2007.08.009

D. Marčinko, et al., "Serum lipid levels and suicidality among male patients with schizoaffective disorder", Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, br. 1, str. 193-196, Siječanj 2008. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:549215. [Citirano: 09.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:549215
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Serum lipid levels and suicidality among male patients with schizoaffective disorder
AutorDarko Marčinko
AutorVesna Marčinko
AutorDalibor Karlović
AutorAnita Marčinko
AutorMarko Martinac
AutorDražen Begić
AutorMiro Jakovljević
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Suicidal behavior in schizoaffective disorder is a serious problem and suicide risk during lifetime ranges between 5%–10%. Neurobiology of suicidal behavior has not been studied sufficiently, and a high number of studies are oriented toward lipid investigation. The aim of our study was to investigate whether there were differences in the level of lipids (cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) in hospitalized suicidal (n = 20) and non-suicidal (n = 20) patients with schizoaffective disorder. The study also included male healthy control subjects (n = 20). Hamilton Depression Rating Scale (HDRS-17), and Positive and Negative Syndrome Scale (PANSS) were used to confirm the level of psychopathology in patients with schizoaffective disorder. Severity of suicidality was measured by Scale for Suicide Ideation (SSI) at time of admission. Results of the study indicated significantly lower concentrations of cholesterol (p < 0.001), LDL-cholesterol (p < 0.01) and HDL-cholesterol (p < 0.01). There were no differences in the number of previous hospitalization and previous suicide attempts between suicidal and non-suicidal patients (p > 0.05). Duration of the illness was significantly (p < 0.05) shorter in suicidal patients. Suicidal patients also had a significantly higher score on HDRS-17 (p < 0.001) and PANSS (p < 0.01) compared to non-suicidal patients.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaProgress in Neuro-Psychopharmacology and Biological Psychiatry
Brojčani podacivol. 32, br. 1, str. 193-196
p-ISSN0278-5846
DOIhttps://doi.org/10.1016/j.pnpbp.2007.08.009
URN:NBNurn:nbn:hr:105:549215
Datum objave publikacije2008-01
URL dokumentahttps://doi.org/10.1016/j.pnpbp.2007.08.009
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 09:10:07